Patent details

Basic Information

Publication number:

EP1505965

PCT Application Number:

PCT/EP/2003/004997

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037498920

PCT Publication Number:

WO/2003/094915

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF THE METABOLITE OF VALSARTAN TO INHIBIT PLATELET AGGREGATION

French Title of Invention:

UTILISATION DU METABOLITE DE VALSARTAN POUR INHIBER L'AGREGATION PLAQUETTAIRE

German Title of Invention:

VERWENDUNG DES METABOLITS VON VALSARTAN ZUR HEMMUNG DER THROMBOZYTENAGGREGATION

SPC Number:

Dates

Filing date:

13/05/2003

Grant date:

02/08/2006

EP Publication Date:

02/08/2006

PCT Publication Date:

20/11/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/02/2005

EP B1 Publication Date:

02/08/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/05/2012

Expiration date:

13/05/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/05/2003

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

SEREBRUANY Victor, L.

Address:

United States (US)

2

Name:

MALININ Alex

Address:

United States (US)

3

Name:

WEBB Randy, Lee

Address:

United States (US)

Priority

1

Priority Number:

380373 P

Priority Date:

14/05/2002

Priority Country:

United States (US)

2

Priority Number:

395014 P

Priority Date:

11/07/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/41;

Filing date	Document type	Number of pages